Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

36.44 -0.72 (-1.95%)
Delayed Quote Updated: 10:28 AM EST, Nov 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Castle Biosciences, Inc. - Common stock

< Previous 1 2 3 4 Next >
News headline image
Castle Biosciences Raises Outlook as Melanoma, TissueCypher Tests Gain Traction ↗
Castle Biosciences (NASDAQ:CSTL) reported continued momentum in its core diagnostic franchises during the second quarter, prompting the company to raise its outlook by more than the amount of its... 
Via MarketBeat
News headline image
Castle Biosciences (CSTL) Q2 2026 Earnings Call Transcript ↗
Revenue hit $103.5 million, up 20% YoY, as TissueCypher surged 63%. 
Via The Motley Fool
Topics Earnings
News headline image
Castle Biosciences Q2 Earnings Call Highlights ↗
Castle Biosciences (NASDAQ:CSTL) reported second-quarter 2026 revenue of $103.5 million, up 20% from the prior-year period, as growth in its TissueCypher test and other core offerings supported... 
Via MarketBeat
Topics Earnings
Castle Biosciences (NASDAQ:CSTL) Surges After Smashing Q2 Estimates and Raising Guidance ↗
Via Chartmill
Castle Biosciences Inc (NASDAQ:CSTL) Beats Q1 Estimates, Raises Full-Year Guidance ↗
Via Chartmill
Castle Biosciences Inc (NASDAQ:CSTL) Reports Q4 2025 Revenue Beat Amid Profitability Transition ↗
Via Chartmill
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 4, 2025 ↗
 
Via Benzinga
News headline image
Castle (CSTL) Q1 2026 Earnings Transcript ↗
Castle (CSTL) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
This $56 Million Sale Slashed One Fund's DigitalBridge Stake Amid 49% Stock Surge ↗
DigitalBridge Group operates at the forefront of digital infrastructure, managing assets critical to global connectivity and data growth. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
This Fund Just Disclosed a $29 Million Sale of a Beauty Stock Up 20% This Past Year ↗
e.l.f. Beauty delivers cosmetics and skin care through a multi-channel model, with recent filings highlighting strong revenue growth. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What's Behind This $32 Million Bet on Baidu Amid a 36% Stock Rally? ↗
Baidu delivers online marketing, cloud, and AI-powered services to businesses and consumers across China’s digital economy. 
Via The Motley Fool
Topics Artificial Intelligence Economy Regulatory Compliance
News headline image
Castle Biosciences (CSTL) Earnings Transcript ↗
Castle Biosciences (CSTL) Earnings Transcript 
Via The Motley Fool
News headline image
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗
This telecom provider delivers fiber, cloud, and security services to businesses and consumers across U.S. and international markets. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
AIGH Capital Dumps 1.1 Million MaxLinear (MXL) Shares ↗
This semiconductor company provides integrated RF and mixed-signal solutions for broadband, wireless, and industrial connectivity. 
Via The Motley Fool
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
Via Chartmill
News headline image
Why Castle Biosciences' Rally Might Just Be Getting Started ↗
Castle Biosciences' bullish structure is strengthening as momentum builds ahead of a possible breakout. 
Via Benzinga
News headline image
AMD To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
A Glimpse of Castle Biosciences's Earnings Potential ↗
 
Via Benzinga
News headline image
Here are the top movers in Tuesday's session. ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Tuesday's session: top gainers and losers ↗
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
These stocks are moving in today's pre-market session ↗
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Castle (CSTL) Q2 Revenue Tops Estimates ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Castle Biosciences Inc (NASDAQ:CSTL) Surges After Posting Strong Q2 2025 Earnings Beat ↗
Castle Biosciences (CSTL) Q2 2025 earnings beat estimates with $86.19M revenue & $0.15 EPS, driving a 6% after-hours surge. Strong test volume growth fuels optimism. 
Via Chartmill
Topics Earnings
News headline image
Examining the Future: Castle Biosciences's Earnings Outlook ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.